TianYu Bio-Technology Co., Ltd. (SHA:603717)
China · Delayed Price · Currency is CNY 7.54
+0.69 (10.07%)
Apr 30, 2026, 3:00 PM CST
TianYu Bio-Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -102.02 | -107.36 | -461.64 | -279.41 | -214.74 |
Depreciation & Amortization | 59.37 | 64.45 | 64.65 | 43.7 | 18.12 |
Other Amortization | 1.72 | 1.25 | 0.99 | 0.73 | 0.9 |
Loss (Gain) From Sale of Assets | -25.97 | 0.67 | -0.99 | -47.44 | -8.81 |
Asset Writedown & Restructuring Costs | 16.14 | 7.93 | 14.97 | 58.57 | 1.8 |
Loss (Gain) From Sale of Investments | 4.11 | 0.21 | 109.7 | -1.84 | -17.47 |
Provision & Write-off of Bad Debts | - | 20.41 | 2.2 | 247.64 | 170.58 |
Other Operating Activities | 56.08 | 76.84 | 17.4 | 93.78 | 46.9 |
Change in Accounts Receivable | 60.73 | -56.56 | 29.49 | -290.33 | -84.1 |
Change in Inventory | 211.89 | 95.26 | 56.14 | 64.42 | -33.24 |
Change in Accounts Payable | -26.88 | 30.38 | 2.29 | 259.98 | -80.5 |
Change in Other Net Operating Assets | - | -1.35 | 0.56 | 1.36 | - |
Operating Cash Flow | 258.3 | 135.29 | -175.93 | 105.53 | -223.32 |
Operating Cash Flow Growth | 90.93% | - | - | - | - |
Capital Expenditures | -53.48 | -54.02 | -84.54 | -83.34 | -6.93 |
Sale of Property, Plant & Equipment | 0.2 | 0.53 | 0.03 | 220.09 | 21.63 |
Cash Acquisitions | -60.51 | -15.86 | -6.94 | -0.56 | 0 |
Divestitures | - | -0.99 | 2.4 | 0.16 | - |
Investment in Securities | -2.05 | -0.57 | 1.76 | -209.33 | 64.75 |
Other Investing Activities | -7.13 | 4.53 | -9.87 | 5.58 | - |
Investing Cash Flow | -122.96 | -64.89 | -102.24 | -93.63 | 79.45 |
Short-Term Debt Issued | - | - | - | 139.5 | 297.1 |
Long-Term Debt Issued | 115.93 | 486.88 | 629.11 | 884.28 | 568.05 |
Total Debt Issued | 115.93 | 486.88 | 629.11 | 1,024 | 865.15 |
Short-Term Debt Repaid | - | - | - | -189.5 | -272.3 |
Long-Term Debt Repaid | -172.62 | -492.61 | -438.57 | -798.36 | -807.14 |
Total Debt Repaid | -172.62 | -492.61 | -438.57 | -987.86 | -1,079 |
Net Debt Issued (Repaid) | -56.69 | -5.73 | 190.53 | 35.91 | -214.29 |
Issuance of Common Stock | - | - | 0.71 | - | 396.57 |
Common Dividends Paid | -50.06 | -43.31 | -43.81 | -56.32 | -50.08 |
Other Financing Activities | -37.97 | -16.22 | -15.78 | 73.71 | 73.71 |
Financing Cash Flow | -144.72 | -65.26 | 131.66 | 53.3 | 205.92 |
Foreign Exchange Rate Adjustments | 0.06 | 0.09 | - | - | - |
Net Cash Flow | -9.33 | 5.23 | -146.51 | 65.2 | 62.05 |
Free Cash Flow | 204.82 | 81.27 | -260.48 | 22.19 | -230.25 |
Free Cash Flow Growth | 152.03% | - | - | - | - |
Free Cash Flow Margin | 28.23% | 10.14% | -38.85% | 2.35% | -36.09% |
Free Cash Flow Per Share | 0.71 | 0.28 | -0.90 | 0.09 | -0.87 |
Cash Income Tax Paid | 16.32 | 14.15 | 10.44 | 28.76 | 33.96 |
Levered Free Cash Flow | 231.11 | 241.07 | -96.83 | 81.23 | -304.4 |
Unlevered Free Cash Flow | 231.11 | 263.9 | -77.73 | 99.47 | -273.93 |
Change in Working Capital | 248.86 | 70.89 | 76.79 | -10.19 | -220.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.